Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
Tethys Bio
Save
Tethys Bio
Develops and commercializes biological markers for use in the diagnosis of metabolic diseases.
Launch date
2002
Employees
11-50 people
Market cap
-
Enterprise valuation
CAD136—205m
(Dealroom.co estimates Oct 2009.)
Emeryville California (HQ)
http://tethysbio.com
https://twitter.com/hdltweets
https://www.linkedin.com/company/tethys-bioscience-inc.
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
biotech and pharma
diabetes
health diagnostics
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Tethys Bio funding
Tethys Bio investors
Edit
Date
Investors
Amount
Round
Oct 2005
Mohr Davidow Ventures
$5.4m
Series A
Jan 2008
Intel Capital
Kleiner Perkins
Greenspring Associates
Mohr Davidow Ventures
N/A
Series C
Oct 2009
Intel Capital
Kleiner Perkins
Calibrium
Mohr Davidow Ventures
$25.0m
Series D
Jul 2010
Standard Treasury
Oxford Finance
$10.0m
Debt
Jan 2012
Armentum Partners
$12.0m
Debt
Total Funding
CAD41.5m
Related Content
Recent News about Tethys Bio
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Tethys Bio
Edit
Lipomics Technologies
ACQUISITION by Metabolon Aug 2012
